SHARA BECKWITH: Open Payments
NPI 1609864974 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,713 in 140 payments from 22 companies in 2025. Trend: 2023 $2,076 · 2024 $2,435 · 2025 $2,713
Food & beverage: $2,713
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $422 |
| ABBVIE INC. | 23 | $354 |
| AstraZeneca Pharmaceuticals LP | 18 | $350 |
| PFIZER INC. | 14 | $280 |
| Corcept Therapeutics | 5 | $189 |
| Lilly USA, LLC | 11 | $177 |
| GlaxoSmithKline, LLC. | 11 | $166 |
| Phathom Pharmaceuticals, Inc. | 5 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $137 |
| Lundbeck LLC | 4 | $84 |
Products named: AIRSUPRA, UBRELVY, Wegovy, Korlym, VOQUEZNA, NURTEC ODT, TRINTELLIX, Ozempic.
Industry payments across MS — which companies pay providers there.
